Global and United States CRM Software in Pharma and Biotech Market Report & Forecast 2022-2028

SKU ID : QYR-20827837 | Publishing Date : 03-May-2022 | No. of pages : 114

CRM for pharmaceutical and biotech companies is a set of specialized capabilities that are part of the pharma selling model. CRM for pharma is optimized to inform a doctor and other stakeholders about products to improve patient outcomes. Key functionality required for pharma CRM solutions includes account management, call planning, call reporting, sample management (including electronic signature capture), time-off territory management, offline functionality and mobile reporting.
Market Analysis and Insights: Global and United States CRM Software in Pharma and Biotech Market
This report focuses on global and United States CRM Software in Pharma and Biotech market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global CRM Software in Pharma and Biotech market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Cloud Based accounting for % of the CRM Software in Pharma and Biotech global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, SMEs was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the CRM Software in Pharma and Biotech market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global CRM Software in Pharma and Biotech Scope and Market Size
CRM Software in Pharma and Biotech market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global CRM Software in Pharma and Biotech market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the CRM Software in Pharma and Biotech market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Cloud Based
On-premises
Segment by Application
SMEs
Large Enterprises
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Veeva Systems
Indegene
Creatio
Cirrius
Trueblue
Pitcher
Aurea
Prolifiq
StayinFront
Euris
Infonis International
Interactive Medica
Ivy Insights
Media-Soft
Navicon
Inova Software
Oracle
Synergistix
QuintilesIMS

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
PRICE
4350
8700

5075


  • market Reports market Reports